Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus

Area of Science:

• Gastroenterology
• Oncology
• Surgical Endoscopy

Background:

• Esophageal adenocarcinoma incidence is rising, with high mortality if not detected early.
• Barrett's esophagus is the primary risk factor, but surveillance effectiveness remains debated.
• UK surveillance programs are not routine, necessitating evaluation of rigorous protocols.

Purpose of the Study:

• To determine if a rigorous endoscopic surveillance protocol improves early esophageal cancer detection rates.
• To compare cancer detection rates between informal and rigorous surveillance methods.
• To assess the impact of a structured surveillance protocol on curative treatment outcomes.

Main Methods:

• Retrospective analysis of informal surveillance (1992-1997) and prospective analysis of a rigorous protocol (1997-1998).
• Inclusion of patients with Barrett's esophagus or adenocarcinoma at Havering Hospitals NHS Trust.
• Analysis of cancer diagnoses in non-surveilled patients during concurrent periods for comparison.

Main Results:

• Rigorous surveillance detected 4.6% (2 cancers, 3 high-grade dysplasias) versus 1% (1 high-grade dysplasia) with informal surveillance.
• Cancer detection in previously undiagnosed Barrett's esophagus was 3.8% (1992-1997) and increased to 10.2% (1997-1998) under the rigorous protocol.
• Curative resections were achieved for T1 lesions, with some detected solely through the multiple biopsy protocol.

Conclusions:

• A rigorous biopsy protocol significantly enhances the detection of early esophageal cancer in Barrett's esophagus.
• Implementing structured surveillance protocols can improve early diagnosis and treatment opportunities.
• The findings support the adoption of rigorous surveillance for patients with Barrett's esophagus.